Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,059 | -46,459 | -35,633 | -24,491 | -12,908 |
| Depreciation Amortization | 119 | 422 | 278 | 183 | 92 |
| Other Working Capital | -354 | -1,978 | 5,144 | 5,481 | 3,581 |
| Other Operating Activity | 601 | 1,751 | 1,244 | 807 | 444 |
| Operating Cash Flow | $-6,693 | $-46,264 | $-28,967 | $-18,020 | $-8,791 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,725 | -17,847 | -17,395 | -4,165 | N/A |
| PPE Investments | -22 | -458 | -424 | N/A | N/A |
| Investing Cash Flow | $1,703 | $-18,305 | $-17,819 | $-4,165 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 54,014 | 53,879 | 53,879 | 54,911 |
| Financing Cash Flow | $N/A | $54,014 | $53,879 | $53,879 | $54,911 |
| Beginning Cash Position | 6,260 | 16,815 | 16,815 | 16,815 | 16,815 |
| End Cash Position | 1,270 | 6,260 | 23,908 | 48,509 | 62,935 |
| Net Cash Flow | $-4,990 | $-10,555 | $7,093 | $31,694 | $46,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,693 | -46,264 | -28,967 | -18,020 | -8,791 |
| Capital Expenditure | -22 | -458 | -424 | N/A | N/A |
| Free Cash Flow | -6,715 | -46,722 | -29,391 | -18,020 | -8,791 |